# FDA Inspection 831630 - Biomat USA Inc - April 10, 2013

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/0b808da5-29f8-4d9d-820e-2f87cd01cd7e
Source feed: FDA_Inspections

> FDA Inspection 831630 for Biomat USA Inc on April 10, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 831630
- Company Name: Biomat USA Inc
- Inspection Date: 2013-04-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1249375 - 2024-08-14](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5de691eb-3fbc-4884-b4d9-bbe66c309136)
- [FDA Inspection 1096834 - 2019-06-25](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6bfa1d8c-a41e-4ab1-ac05-8eac703eef3b)
- [FDA Inspection 1014325 - 2017-04-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3cdb9466-f919-4fde-b8dd-cd2b15dc5e86)
- [FDA Inspection 921477 - 2015-04-09](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a1eb0fe4-dd8c-454b-9a32-4f000d696d9a)
- [FDA Inspection 722294 - 2011-04-28](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/bc5bf1b3-981e-4d46-b4d3-0a5f58c23833)

Company: https://www.keypedia.com/companies/biomat-usa-inc/1e88dca4-643e-4e48-981c-9b5d30c64ad6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d